🇺🇸 FDA
Patent

US 11549127

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

granted A61KA61K38/465A61K48/00

Quick answer

US patent 11549127 (Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription) held by The Regents of the University of California expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K38/465, A61K48/00, A61P, A61P31/00